Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guarneri

Showing results (1141-1150 of 1,433) with videos related to

Pageof 144
Sort By:
Cancers|November 26, 2022
The Multidisciplinary Approach in Stage III Non-Small Cell Lung Cancer over Ten Years: From Radiation Therapy Optimisation to Innovative Systemic TreatmentsAlessandra Ferro, Matteo Sepulcri, Marco Schiavon, et al.
Oncology|March 1, 1997
Paclitaxel plus ifosfamide in advanced ovarian cancer: a multicenter phase II studyL Miglietta, D Amoroso, M Bruzzone, et al.
Integrative Zoology|June 17, 2024
Amphioxus (Branchiostoma lanceolatum) in the North Adriatic Sea: ecological observations and spawning behaviorIrene Guarneri, Matteo Bozzo, Natalia Perez Criado, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 15, 2016
PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumabS Loibl, I Majewski, V Guarneri, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 31, 2002
Continuous subcutaneous insulin infusion (CSII) in the Veneto region: efficacy, acceptability and quality of lifeD Bruttomesso, A Pianta, D Crazzolara, et al.
NPJ Breast Cancer|August 3, 2021
Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapyMaria Vittoria Dieci, Gaia Griguolo, Michele Bottosso, et al.
NPJ Breast Cancer|May 20, 2022
HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatmentFederica Miglietta, Gaia Griguolo, Michele Bottosso, et al.
European Journal of Cancer (Oxford, England : 1990)|August 5, 2018
The role of immune microenvironment in small-cell lung cancer: Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumour infiltrating lymphocytesL Bonanno, A Pavan, M V Dieci, et al.
Journal of Biological Regulators and Homeostatic Agents|July 5, 2016
Uncommon clinical presentation of Kimura’s disease as bilateral retroauricular masses in a young Malian male: successful surgical approachF Fama, A Sindoni, G Tchernev, et al.
The Oncologist|April 21, 2026
Long-term outcome of isolated locoregional (ILRR) breast cancer (BC) recurrence: a large retrospective Mono-institutional studyGrazia Vernaci, Gaia Griguolo, Fabio Girardi, et al.
Pageof 144

Showing results (1141-1150 of 1,433) with videos related to

Sort By:
Pageof 144
Cancers|November 26, 2022
The Multidisciplinary Approach in Stage III Non-Small Cell Lung Cancer over Ten Years: From Radiation Therapy Optimisation to Innovative Systemic TreatmentsAlessandra Ferro, Matteo Sepulcri, Marco Schiavon, et al.
Oncology|March 1, 1997
Paclitaxel plus ifosfamide in advanced ovarian cancer: a multicenter phase II studyL Miglietta, D Amoroso, M Bruzzone, et al.
Integrative Zoology|June 17, 2024
Amphioxus (Branchiostoma lanceolatum) in the North Adriatic Sea: ecological observations and spawning behaviorIrene Guarneri, Matteo Bozzo, Natalia Perez Criado, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 15, 2016
PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumabS Loibl, I Majewski, V Guarneri, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 31, 2002
Continuous subcutaneous insulin infusion (CSII) in the Veneto region: efficacy, acceptability and quality of lifeD Bruttomesso, A Pianta, D Crazzolara, et al.
NPJ Breast Cancer|August 3, 2021
Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapyMaria Vittoria Dieci, Gaia Griguolo, Michele Bottosso, et al.
NPJ Breast Cancer|May 20, 2022
HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatmentFederica Miglietta, Gaia Griguolo, Michele Bottosso, et al.
European Journal of Cancer (Oxford, England : 1990)|August 5, 2018
The role of immune microenvironment in small-cell lung cancer: Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumour infiltrating lymphocytesL Bonanno, A Pavan, M V Dieci, et al.
Journal of Biological Regulators and Homeostatic Agents|July 5, 2016
Uncommon clinical presentation of Kimura’s disease as bilateral retroauricular masses in a young Malian male: successful surgical approachF Fama, A Sindoni, G Tchernev, et al.
The Oncologist|April 21, 2026
Long-term outcome of isolated locoregional (ILRR) breast cancer (BC) recurrence: a large retrospective Mono-institutional studyGrazia Vernaci, Gaia Griguolo, Fabio Girardi, et al.
Pageof 144